![](https://investorshub.advfn.com/uicon/315468.png?cb=1473363790)
Thursday, August 05, 2021 2:15:26 PM
From the article:
"The company has completed Phase 1 clinical trials for RPI-78M, but these results have not been published."
"In September 2016, Nutra Pharma announced a partnership with Omnia Biologics to prepare for the upcoming clinical trials. Omnia Biologics will clone and purify the alpha-cobratoxin gene required to produce RPI-78M. Nutra Pharma has announced a similar collaboration on May 31, 2017, with the University of Maryland’s Bioprocess Scale-up Facility (BSF), which will aim to optimize the sustainable production of RPI-78M at high quality, using the cloned gene."
Well none of that is true and oddly Deitsch hasn't published the results from the clinical trials.
Why isn't the research and clinical trials listed on ClinicalTrials.gov? Deitsch hasn't started any FDA approved clinical trials.
IG
"The Hour Between Dog and Wolf"
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM